Is there an association between neurocognitive performance and medication adherence in first episode psychosis?

Early Intervention in Psychiatry

Volumn 4, Issue 2, 2010, Pages 189-195

  Lepage, Martin ^a   Bodnar, Michael ^a   Joober, Ridha ^a   Malla, Ashok ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Cognition; Medication adherence; Medication compliance; Psychosis; Schizophrenia

Indexed keywords

CLOZAPINE; HALOPERIDOL; LOXAPINE SUCCINATE; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; AFFECTIVE PSYCHOSIS; ARTICLE; ATTENTION; CONTROLLED STUDY; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROBLEM SOLVING; PSYCHOSIS; SCHIZOPHRENIA; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY; COGNITION; INTELLIGENCE TEST; MEDICATION COMPLIANCE; PSYCHOLOGY; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

COGNITION; FEMALE; HUMANS; INTELLIGENCE TESTS; MALE; MEDICATION ADHERENCE; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77953226733     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/j.1751-7893.2010.00174.x     Document Type: Article

References (23)

1. Malla A, Norman R, Schmitz N. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol Med 2006, 36:649-58.
2. Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry 2006, 67:453-60.
3. Malla AK, Norman RM, Manchanda R, Townsend L. Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychol Med 2002, 32:1109-19.
4. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997, 23:637-51.
5. Adams SG, Howe JT. Predicting medication compliance in a psychotic population. J Nerv Ment Dis 1993, 181:558-60.
6. Buchanan A. A two-year prospective study of treatment compliance in patients with schizophrenia. Psychol Med 1992, 22:787-97.
7. Kemp R, David A. Psychological predictors of insight and compliance in psychotic patients. Br J Psychiatry 1996, 169:444-50.
8. Smith TE, Hull JW, Goodman M. The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis 1999, 187:102-8.
9. Donohoe G, Owens N, O'Donnell C. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis. Eur Psychiatry 2001, 16:293-8.
10. Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S, Jeste DV. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr Res 2003, 63:49-58.
11. Robinson DG, Woerner MG, Alvir JM, Bilder RM, Hinrichsen GA, Lieberman JA. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr Res 2002, 57:209-19.
12. Perkins DO, Gu H, Weiden PJ, McEvoy JP, Hamer RM, Lieberman JA. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. J clin psychiatry 2008, 69:106-13.
13. Bodnar M, Malla A, Joober R, Lepage M. Cognitive markers of short-term clinical outcome in first-episode psychosis. Br J Psychiatry 2008, 193:297-304.
14. Andreasen N. Scale for the Assessment of Positive Symptoms (SAPS) 1984, Iowa City, IA, The University of Iowa
15. Andreasen NC. Modified Scale for the Assessment of Negative Symptoms (SANS) 1984, Iowa City, IA, University of Iowa
16. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res 2004, 72:29-39.
17. Lepage M, Buchy L, Bodnar M, Bertrand MC, Joober R, Malla A. Cognitive insight and verbal memory in first episode of psychosis. Eur Psychiatry 2008, 23:368-74.
18. Perkins DO, Johnson JL, Hamer RM. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res 2006, 83:53-63.
19. Emsley R, Medori R, Koen L, Oosthuizen PP, Niehaus DJ, Rabinowitz J. Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: a preliminary study. J Clin Psychopharmacol 2008, 28:210-3.
20. Addington J, Saeedi H, Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophr Res 2005, 78:35-43.
21. Verdoux H, Liraud F, Assens F, Abalan F, van Os J. Social and clinical consequences of cognitive deficits in early psychosis: a two-year follow-up study of first-admitted patients. Schizophr Res 2002, 56:149-59.
22. Kane JM. Treatment adherence and long-term outcomes. CNS Spectr 2007, 12(17):21-6. Suppl.
23. Miller BJ. A review of second-generation antipsychotic discontinuation in first-episode psychosis. J Psychiatr Pract 2008, 14:289-300.